Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: Identification of a potent and selective 5-HT6 receptor antagonist showing activity in rat social recognition test-Reference-Cited by-同舟云学术

Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: Identification of a potent and selective 5-HT6 receptor antagonist showing activity in rat social recognition test

Published:2012-02 Issue:3 Volume:22 Page:1421-1426
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Tripathy Rabindranath,McHugh Robert J.,Bacon Edward R.,Salvino Joseph M.,Morton George C.,Aimone Lisa D.,Huang Zeck,Mathiasen Joanne R.,DiCamillo Amy,Huffman Mark J.,McKenna Beth A.,Kopec Karla,Lu Lily D.,Qian Jie,Angeles Thelma S.,Connors Thomas,Spais Chrysanthe,Holskin Beverly,Duzic Emir,Schaffhauser Hervé,Rossé Gerard C.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference39 articles.

1. Episodic memory decay along the adult lifespan: A review of behavioral and neurophysiological evidence

3. Working Memory and Learning in Early Alzheimer?s Disease

4. Memory loss in Alzheimer’s disease: implications for development of therapeutics

5. Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poor Decision Making and Sociability Impairment Following Central Serotonin Reduction in Inducible TPH2-Knockdown Rats;International Journal of Molecular Sciences;2024-05-03

2. Poor decision making and sociability impairment following central serotonin reduction in inducible TPH2-knockdown rats;2024-01-08

3. Polypharmacological drug design opportunities against Parkinson's disease;F1000Research;2022-10-17

4. 5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia;Journal of Clinical Psychopharmacology;2017-04

5. AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer’s Disease;Molecular Pharmaceutics;2016-02-26